Last reviewed 2026-04-22 · How we verify

Epinephrin 0.07

Epinephrine is a catecholamine that activates alpha and beta adrenergic receptors to increase heart rate, blood pressure, and bronchial dilation.

Epinephrine is a catecholamine that activates alpha and beta adrenergic receptors to increase heart rate, blood pressure, and bronchial dilation. Used for Anaphylaxis, Cardiac arrest, Severe hypotension.

At a glance

Mechanism of action

Epinephrine binds to alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors on target tissues. This activation increases cardiac contractility and heart rate (beta-1), causes vasoconstriction (alpha-1), and promotes bronchial smooth muscle relaxation (beta-2). The 0.07 concentration indicates a dilute formulation typically used for local or systemic administration.

Approved indications

• Anaphylaxis
• Cardiac arrest
• Severe hypotension
• Acute bronchospasm
• Local hemostasis and vasoconstriction in surgical procedures

Common side effects

• Tachycardia
• Hypertension
• Tremor
• Anxiety
• Headache
• Arrhythmias
• Myocardial ischemia

Key clinical trials

• Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects (PHASE1)
• Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Caesarean Section (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Epinephrin 0.07 CI brief — competitive landscape report
• Epinephrin 0.07 updates RSS · CI watch RSS
• Kasr El Aini Hospital portfolio CI